Yukiko K. Kaneko
Shizuoka, 4228526, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Differentiation-inducing factor-1 ameliorates liver fibrosis through the reversion of activated hepatic stellate cells.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 28, 2024
Diacylglycerol kinase ζ is a positive insulin secretion regulator in pancreatic β-cell line MIN6.
Journal: Biochemical and biophysical research communications
Published: October 16, 2024
Effects of phospholipid type and particle size on lipid nanoparticle distribution in vivo and in pancreatic islets.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 15, 2024
Oral ingestion of Shiikuwasha extract suppresses diabetes progression in db/db mice by preserving β-cell mass.
Journal: Frontiers in nutrition
Published: November 10, 2023
GDP-bound Rab27a regulates clathrin disassembly through HSPA8 after insulin secretion.
Journal: Archives of biochemistry and biophysics
Published: May 29, 2023
Development of Therapeutic Agents with a Novel Mechanism of Action Targeting Pancreatic β-Cells for Diabetes.
Journal: Biological & pharmaceutical bulletin
Published: April 30, 2023
Apigenin Alleviates Endoplasmic Reticulum Stress-Mediated Apoptosis in INS-1 β-Cells.
Journal: Biological & pharmaceutical bulletin
Published: April 02, 2023
Asymmetric dimethylarginine accumulation under hyperglycemia facilitates β-cell apoptosis via inhibiting nitric oxide production.
Journal: Biochemical and biophysical research communications
Published: October 19, 2022
Involvement of Diacylglycerol Kinase on the Regulation of Insulin Secretion in Pancreatic β-Cells during Type 2 Diabetes
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: May 01, 2022
Harmine suppresses collagen production in hepatic stellate cells by inhibiting DYRK1B.
Journal: Biochemical and biophysical research communications
Published: February 15, 2022
The sialidase inhibitor 2,3-dehydro-2-deoxy-N-acetylneuraminic acid is a glucose-dependent potentiator of insulin secretion.
Journal: Scientific reports
Published: January 24, 2019
Last Updated: 09/26/2026